SCHEMBL3547253

SCHEMBL3547253

OCC[C@H]1CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9265 1.00
SCHEMBL4361145 1.00
SCHEMBL10686077 0.84 ALDH1A1 (0.43)
Nitric Acid SCHEMBL9158721 0.83 CA5A (0.36)
SCHEMBL18194644 0.81
SCHEMBL50962 0.81
SCHEMBL4658756 0.81
SCHEMBL12045201 0.79
SCHEMBL51837 0.79
SCHEMBL928477 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260001846-A1 SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS SERVIER LAB (FR) 2026-01-01 US disclosed
EP-4551566-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS Les Laboratoires Servier (FR) 2025-05-14 EP disclosed
CN-119816491-A New spirocyclohexane derivatives, pharmaceutical compositions containing them and their use as anti-apoptotic inhibitors 法国施维雅药厂 2025-04-11 CN disclosed
WO-2024008941-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS LES LABORATOIRES SERVIER (FR) 2024-01-11 WO disclosed
US-20230399314-A1 CD73 INHIBITOR AND USE THEREOF Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) 2023-12-14 US disclosed
US-11464853-B2 Amino acid and peptide conjugates and conjugation process AUCKLAND UNISERVICES LIMITED (NZ) 2022-10-11 US disclosed
US-20220133713-A1 SIGMA-2 RECEPTOR BINDERS AND THEIR METHOD OF USE Temple University--of the Commonwealth System of Higher Education 2022-05-05 US disclosed
CN-113454086-A Imidazo [2,1-F ] [1,2,4] triazin-4-amine derivatives as TLR7 agonists 百济神州有限公司 2021-09-28 CN disclosed
US-20200361864-A1 Peptide Conjugates, Conjugation Process, and Uses Thereof AUCKLAND UNISERVICES LTD (NZ) 2020-11-19 US disclosed
EP-3676250-A1 PEPTIDE CONJUGATES, CONJUGATION PROCESS, AND USES THEREOF Auckland Uniservices Limited (NZ) 2020-07-08 EP disclosed
WO-2017145097-A2 AMINO ACID AND PEPTIDE CONJUGATES AND CONJUGATION PROCESS AUCKLAND UNISERVICES LIMITED (NZ) 2017-08-31 WO disclosed
WO-2017145097-A2 AMINO ACID AND PEPTIDE CONJUGATES AND CONJUGATION PROCESS AUCKLAND UNISERVICES LIMITED (NZ) 2017-08-31 WO disclosed
US-9422230-B2 Process for the preparation of an anticonvulsant agent pregabalin hydrochloride COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-08-23 US disclosed
EP-2399916-B1 Process and intermediates for the preparation of aspartic acetal caspase ihnhibitors VERTEX PHARMA (US) 2014-12-10 EP disclosed
EP-1854792-B1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2012-12-26 EP disclosed
US-7820693-B2 1-(2H)-isoquinolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2010-10-26 US disclosed
US-20090030195-A1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2009-01-29 US disclosed
EP-1854792-A1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-11-14 EP disclosed
WO-2003097624-A1 PROCESS FOR PREPARING (R)-3,4-EPOXY-1-BUTANOL SAMSUNG FINE CHEMICALS CO., LTD. (KR) 2003-11-27 WO disclosed
EP-0443197-A2 Oxazolidinones MERCK PATENT GmbH (DE) 1991-08-28 EP disclosed